Islet amyloid polypeptide which is normally coexpressed with insulin in beta cells, forms amyloid deposits especially in islets of Type 2 (non-insulin-dependent) diabetic subjects. Occurrence of islet amyloid is paradoxically associated with loss of islet amyloid polypeptide immunoreactivity in beta cells. The present study was undertaken to examine whether the islet amyloid polypeptide gene is expressed in islets with decreased islet amyloid polypeptide immunoreactivity. Pancreatic tissue from 14 patients, 7 with Type 2 diabetes and 7 non-diabetic, were obtained at autopsy or surgery and studied for islet amyloid polypeptide expression by in situ hybridization and for presence of insulin and islet amyloid polypeptide by immunohistochemistry. Six of the specimens from the diabetic and three of those from the nondiabetic patients had varying degrees of islet amyloid polypeptide-derived islet amyloid. Amyloid deposits were associated with decreased numbers of beta cells with islet amyloid polypeptide immunoreactivity despite an apparent normal frequency of insulin-containing cells. This discrepancy might reflect an alteration in islet amyloid polypeptide production or processing at a transcriptional or post-transcriptional level. In contrast to the varying immunohistochemical patterns, islets of all categories showed strong labelling using an islet amyloid polypeptide probe for in situ hybridization. It is concluded that islet amyloid polypeptide production is not altered at the transcriptional level. The following possibilities remain: (1) islet amyloid polypeptide production may be altered at a post-transcriptional level or (2) that islet amyloid polypeptide production is normal but the reduced immunoreactivity of the cells reflects a reduced storage of IAPP in secretory granules. We favour the second possibility since islet amyloid deposition is incompatible with reduced islet amyloid polypeptide synthesis.
Islet amyloid polypeptide (IAPP) is a 37-amino-acidresidue polypeptide, discovered through its ability to form amyloid deposits in the islets of Langerhans in Type 2 (noninsulin-dependent) diabetes mellitus and in many insulinomas [1] [2] [3] [4] . It is stored together with insulin in the secretory granules [5] [6] [7] as early as during gestation [8] and the two substances are released together after beta-cell stimulation with glucose or other secretagogues [9] [10] [11] . Although IAPP and insulin are normally secreted in parallel, the plasma level of IAPP is only about 1-10 % of that of insulin [10, 12, 13] . Under experimental conditions, a dissociation of the expression of the two polypeptides has been seen [14] . In humans IAPP is encoded by a gene located on chromosome 12 and expressed as an 89 amino-acid-residue prepropolypeptide in which IAPP is flanked by two short propeptides [15] [16] [17] . Processing to mature lAPP includes cleavage at double basic amino acid residues and C-terminal amidation. The way in which IAPP expression is regulated in relation to that of insulin is at present not known.
The normal function of IAPP has not been defined. Experimentally, IAPP has interesting effects on the utilization of glucose in skeletal muscle in that both basal and insulin-stimulated glycogen synthesis is inhibited [18, 19] . At least some of these effects depend on decreased glucose transport [20] . Given intravenously, IAPP can give rise to insulin resistance in experimental animals [21, 22] . However, slightly contradictory results have been obtained and it should be noted that the plasma levels of IAPP found normally are much lower than the levels needed for the described experimental effects [23] .
In normal adult human and rat pancreas, all beta cells are IAPP-positive in immunohistochemistry [2, 8] , although the staining intensity varies. In Type 2 diabetes in humans, and in the diabetic cat, IAPP-derived islet amyloid develops in most individuals. Since islet amyloid is a concentrated form of IAPR one might expect an increased synthesis of IAPP in affected islets. Paradoxically however, most beta cells are negative for IAPP immu-noreactivity in human Type 2 diabetes and in diabetic cats, at least in islets containing amyloid deposits [24, 25] . This is in contrast to the situation regarding insulin for which the islets are still immunoreactive and may indicate that following the development of amyloid, the beta cells enter a state in which the insulin but not the IAPP gene is transcribed. Alternatively, IAPP mRNA is produced but less efficiently translated. A third possibility is that IAPP may be synthesized at a normal rate but becomes rapidly released instead of being stored in secretory granules. The present immunohistochemical and in situ hybridization study was performed in order to discriminate between an alteration at a transcriptional or post-transcriptional level.
Materials and methods
Pancreatic tissue. Pancreatic tissue (corpus or cauda) was obtained at autopsy 3-7 h after the death of seven patients with a history of Type 2 diabetes and five non-diabetic individuals (Tables I and 2 ). In the non-diabetic group several urine tests for glucose had been performed with negative results and in most cases at least one glucose determination with a normal result. Pancreatic tissue from the corpus was also obtained from two patients undergoing subtotal pancreatic resection. One of these patients had pancreatic carcinoma while the other had an ulcer penetrating into the head of the pancreas. Both the patients had normal glucose tolerance. In all instances the specimens were immediately placed on ice and small pieces of the macroscopically normal body of the pancreas were fixed in ice-cold buffered neutral 4% formaldehyde solution. After fixation for about 6 h, the specimens were dehydrated and embedded in paraffin.
Amyloid. Amyloid was identified by alkaline Congo red staining of deparaffinized sections. The sections were studied in polarized light for green birefringence. The percentage of islets containing any amyloid was determined on sections double-stained for amyloid with Congo red and for insulin with the peroxidase-antiperoxidase method (see below). All islets in the section, irrespective of size, were included. At least 100 islets were studied in each case.
Imrnunohistochernistry. Peroxidase-conjugated avidin, biotinylated swine anti-rabbit immunoglobulins, swine anti-rabbit immunoglobulins cross-reacting with guinea pig immunoglobulins and rabbit horseradish peroxidase anti-horseradish peroxidase complex were from Dakopatts (Copenhagen, Denmark). Antiserum to porcine insulin, produced in a guinea pig (Ma37), has been described previously [26] . Antiserum to human IAPP147 (AA116) was raised in a G. T. Westermark et al.: Islet amyloid polypeptide mRNA rabbit by standard methods using synthetic human IAPP [20] . IAPP was linked to keyhole limpet haemocyanin [24] . When used in immunohistochemistry on pancreatic sections from human, cat and rat, antiserum AAl16 labelled islet beta cells specifically and strongly. This reaction was abolished when the antiserum was preabsorbed (10 mg/ml of undiluted antiserum) with the synthetic human IAPP147. Deparaffinized sections were incubated with the primary antiserum (diluted 1:200-1:400 for AA116 and 1:800-1:1600 for Ma37) overnight at room temperature. For demonstration of IAPP immunoreactivity, the avidin-biotin method [27] was used while insulin immunoreactivity was demonstrated by the peroxidaseantiperoxidase method [28] . The reactions were visualized with diaminobenzidine (Sigma, St.Louis, Mo., USA). For control, the primary antisera were replaced with normal rabbit serum. Semiquantitative estimation of the proportions of immunoreactive cells was performed as described [24] .
Probe. A cDNA clone of human preproIAPP has been described previously [16] . A 320 base pair long probe corresponding to the full length coding region of IAPP was amplified by polymerase chain reaction. The RNA polymerase specific Sp6 and T7 promoters were linked to the sense and antisense primers, respectively. A digoxigenated riboprobe was generated by in vitro transcription [29] . Unlabelled nucleotides (NTP) and T7 and Sp6 polymerases were from Pharmacia (Uppsala, Sweden) and digoxigenated UTP and human placenta ribonuclease inhibitor from Boehringer (Mannheim, FRG).
In situ hybridization. This was mainly performed as described previously [29, 30] . Deparaffinized sections, placed on glass slides, were immersed in PBS-Triton (0.15 mol/1 NaC1-0.01 mol/1 sodium phosphate, pH 7.5, containing 0.2 % Triton X-100) and thereafter rinsed in phosphate buffered saline (PBS). Proteinase K (Boehringer) digestion (1 mg/ml in 0.1 mol/1 Tris HC1 buffer, pH 8.0-50 retool/1 EDTA) was performed at 37~ for 10min. The digestion was stopped by immersion in 0.1 mol/1 glycine in PBS for 5 min. The sections were post-fixed in 4% paraformaldehyde-PBS for 3 min, rinsed briefly in PBS, immersed in 0.25 % acetic anhydride-0.1 mol/1 triethanolamine solution, pH 8.0 for 10 min, rinsed briefly in water and prehybridized at 50 ~ for 30 min. The hybridization buffer contained 50% formamide, 5 x SSC ( = 0.75 mol/l sodium chloride and 0.25 mol/1 sodium citrate), 10 % dextran sulphate, 5 x Denhardt's solution (100 • = 2 % Ficoll, 2 % polyvinylpyrrolidone, and 2 % bovine serum albumin), 2 % sodium dodecyl sulphate (SDS), and 100 gg/ml denatured sheared herring sperm DNA (Boehringer). The probe concentration was 2.5 ng/gl and 10 gl were applied to each section. Hybridization was performed with the digoxigenin-labelled probe under a coverslip overnight at 50~ For control, sections were (1)treated with RNase before hybridization, (2)hybridized with two digoxigenized non-related probes (a prolactin sense probe and an IAPP sense probe) or (3)treated identically without addition of any probe. + na 0 -no, 1 + -< 10 %, 2 + = 10-50 % and 3 + -> 50 % immunoreactive cells, respectively, na, Not applicable. The hybridization reactions were not graded After hybridization, the sections were washed extensively in 2 x SSC-0.1% SDS followed by 0.1 x SSC-0.1% SDS. Thereafter, the sections were treated with RNase (Boehringer) (10 mg/ml in 2 x SSC) at 37 ~ for 15 min. The sections were rinsed in 2 x SSC and incubated with alkaline phosphatase-labelled anti-digoxigenin antibodies (Boehringer) for 4-12 h. They were then washed and the reaction was visualized with nitro blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-phosphate in a solution containing 0.1 mol/1 Tris HC1, pH 9.5, 0.1 mol/1 NaC1, 50 mmol/1 MgC12 buffer and levamisole (25 mg/100ml). The reaction was stopped in 20 mmol/1 TrisHC1-5 mmol/1EDTA, pH 7.5.
The in situ hybridization and immuuohistochemical stainings were always performed on three consecutive sections.
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Results
Arnyloid
Islet a m y l o i d was found in six of the diabetic and three of the n o n -d i a b e t i c patients (Tables 1 and 2 ). Extensive deposits in a m a j o r i t y of islets were found in five of the diabetic patients. Table 1 . In islets without amyloid, a n t i s e r u m to I A P P labelled most of the islet cells with a p a t t e r n r e s e m b l i n g that of insulin immunostaining. However, the variation in strength of staining b e t w e e n cells was m u c h greater with a n t i s e r u m to I A P P c o m p a r e d with antiserum to insulin. Cellular processes were often evident (Fig. 1) 
Islet amyloid polypeptide and insulin immunoreactivity
Diabetic patients. The i m m u n o h i s t o c h e m i c a l findings are
given in Table 2 . T h e frequency of insulin-positive cells was not greatly reduced, not even in islets with amyloid (Table 2 ; F i g . 2 a ) . T h e insulin-reaction in the individual b e t a cells was as strong as in islets of n o n -d i a b e t i c individuals. In contrast, a clearly r e d u c e d frequency of I A P Ppositive cells was seen in a m y l o i d -f r e e islets in most of the patients. E v e n m o r e evident was the discrepancy b e t w e e n the n u m b e r of insulin and I A P P -p o s i t i v e cells in islets with amyloid deposits (Fig. 2b) . In the islets of two of the patients, no I A P P -c o n t a i n i n g cells were found while in four, only a few scattered cells occurred.
In situ hybridization
In n o r m a l p a n c r e a t i c tissue, in situ hybridization with the I A P P p r o b e resulted in strong labelling of most of the islet cells (Fig. 3 b) . T h e label was confined to the cytoplasm and was often stronger in parts of the cells. The labelling p a t t e r n was similar to that seen i m m u n o h i s t o c h e m i c a l l y with antisera to I A P P (Fig. 3 a) and insulin (not shown). The labelling intensity varied s o m e w h a t b e t w e e n cells. The exocrine p a r e n c h y m a l cells showed no label. The specificity of the reaction was verified by hybridization following R N a s e t r e a t m e n t or after hybridization with the 0 --no, 1 + = < 10 %, 2 + = 10-50 % and 3 + = > 50 % immunoreactive cells, respectively, na, Not applicable. The hybridization reactions were not graded sense probes. These procedures gave negative results as did omission of the probe. In pancreases with islet amyloid deposits from both diabetic and non-diabetic patients, the majority of islet cells also showed positive in situ hybridization. This signal varied somewhat from tissue to tissue but no attempt was made to quantitate the reaction. In contrast to the immunohistochemical findings, islets with amyloid deposits, including those of the diabetic patients with pronounced islet amyloidosis, exhibited a strong IAPP signal (Fig. 2 c) which did not differ significantly from that seen in islets without amyloid in diabetic and non-diabetic patients. The signal was similar to the pattern obtained with the immunohistochemical staining for insulin (Fig. 2 a) .
Discussion
The human pancreas is comparatively difficult to study histologically due to the problems in obtaining tissue suitable for immunohistochemistry. The availability of fresh specimens is limited and for post-mortem material to be useful, autopsy must be performed very soon after death. Nevertheless, autopsy material is sometimes useful, even for m R N A hybridization, as shown in the present study with an IAPP probe and as previously shown for insulin m R N A [3t].
IAPP is selectively stored in the beta cells in the human pancreas [8, 24] , and in normal tissue IAPP and insulin immunoreactivities are distributed identically. We do not know exactly why IAPP gives rise to amyloid in Type 2 diabetes. One important factor is the primary structure within a central segment of the human (and cat) IAPP molecule which determines its ability to aggregate as amyloid fibrils [16, 32] . One other factor may be an overproduction of the polypeptide. This possibility has been supported by the finding of an increased IAPP immunoreactivity in the beta cells of glucose intolerant but not overtly diabetic cats [25] . It has therefore been surprising that instead of increased immunoreactivity, a greatly reduced beta-cell lAPP immunoreactivity occurs in Type 2 diabetes in humans [24] and in diabetic cats [25] . The most important finding in the present investigation is therefore that IAPP m R N A is present in beta cells in islets with amyloid deposits, whether light or heavy, and to the same extent as in normal islets, as far as can be judged from in situ hybridization.
The absence of IAPP immunoreactivity despite the presence of IAPP m R N A can be due to two possible mechanisms. One possibility is that transcription of the IAPP gene occurs but with no or with only a very low degree of translation. The other possibility is that there is an Fig. 2 a--e. Consecutive sections of an islet, rich in amyloid (A), from a Type 2 diabetic patient, a The section was immunostained for insulin and b for IAPR Only few of the insulin-labelled cells in a react with the antiserum to IAPP (arrows). c The same islet (slightly rotated) was subjected to in situ hybridization with an IAPP probe as in Figure 1 . The distribution of the reaction product is identical with the staining pattern for insulin but differs dramatically from the labelling pattern with the antiserum to IAPR Magnification x 370 on-going I A P P p r o d u c t i o n but that n o r m a l storage of I A P P in secretory granules is hindered. A l t h o u g h the latter e x p l a n a t i o n remains to be confirmed, it seems to be the most plausible for at least two reasons. Firstly, in one study it was f o u n d that the a m o u n t of islet a m y l o i d increases with the d u r a t i o n of d i a b e t e s [33] for which an on-going p r o d u c t i o n of I A P P is a prerequisite. Secondly, the p l a s m a levels of I A P P in Type 2 diabetic patients are not significantly lower as c o m p a r e d to n o n -d i a b e t i c subjects [10, 13] . However, further studies are n e e d e d to elucidate the exact nature of cellular a b n o r m a l i t y leading to loss of l A P P imm u n o r e a c t i v i t y in b e t a cells and to islet amyloid.
A l l diabetic patients h a d b e e n t r e a t e d with sulphonylureas. W h e t h e r such t r e a t m e n t affects I A P P expression or secretion is still to be studied.
